series-a
Stage
1
Investors
About
Nevia Bio is a diagnostics company developing liquid‑biopsy tests that analyze vaginal fluid to enable earlier detection, monitoring, and treatment guidance for gynecological conditions, initially targeting ovarian cancer.
Explore Nevia Bio's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.